Comment
doi: 10.1016/j.clon.2016.03.006.
Epub 2016 May 4.
High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical Practice
Affiliations
- PMID: 27131755
- DOI: 10.1016/j.clon.2016.03.006
Item in Clipboard
Comment
High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical Practice
Clin Oncol (R Coll Radiol).
2016 Sep.
No abstract available
Comment in
-
Response to 'High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical Practice', by Tanguay et al.Clin Oncol (R Coll Radiol). 2016 Oct;28(10):666-7. doi: 10.1016/j.clon.2016.07.004. Epub 2016 Jul 29. Clin Oncol (R Coll Radiol). 2016. PMID: 27477123 No abstract available.
Comment on
-
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.Lancet. 2016 Mar 19;387(10024):1163-77. doi: 10.1016/S0140-6736(15)01037-5. Epub 2015 Dec 21. Lancet. 2016. PMID: 26719232 Free PMC article. Clinical Trial.
Similar articles
-
Response to 'High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical Practice', by Tanguay et al.Clin Oncol (R Coll Radiol). 2016 Oct;28(10):666-7. doi: 10.1016/j.clon.2016.07.004. Epub 2016 Jul 29. Clin Oncol (R Coll Radiol). 2016. PMID: 27477123 No abstract available.
-
Real-world uptake, safety profile and outcomes of docetaxel in newly diagnosed metastatic prostate cancer.BJU Int. 2018 Feb;121(2):268-274. doi: 10.1111/bju.14025. Epub 2017 Oct 15. BJU Int. 2018. PMID: 28940952
-
Should docetaxel be administered earlier in prostate cancer therapy?Expert Rev Anticancer Ther. 2015;15(9):977-9. doi: 10.1586/14737140.2015.1074042. Epub 2015 Jul 29. Expert Rev Anticancer Ther. 2015. PMID: 26223224
-
Docetaxel in prostate cancer.Anticancer Drugs. 2001 Feb;12 Suppl 1:S17-20. Anticancer Drugs. 2001. PMID: 11340899 Review.
-
Docetaxel (Taxotere)-based chemotherapy for hormone-refractory and locally advanced prostate cancer.Semin Oncol. 1999 Oct;26(5 Suppl 17):49-54. Semin Oncol. 1999. PMID: 10604270 Review.
Cited by
-
Impact of treatment on progression to castration-resistance, metastases, and death in men with localized high-grade prostate cancer.Cancer Med. 2017 Jan;6(1):163-172. doi: 10.1002/cam4.981. Epub 2016 Dec 20. Cancer Med. 2017. PMID: 27997745 Free PMC article.
-
Cardiovascular Effects of Metabolic Surgery on Type 2 Diabetes.Curr Cardiol Rev. 2020;16(4):275-284. doi: 10.2174/1573403X16666200220120226. Curr Cardiol Rev. 2020. PMID: 32077829 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
